C. Otto

发表

Long-term reduction of C-reactive protein concentration by regular LDL apheresis.

K. Empen, K. Parhofer, C. Otto, 2004, Atherosclerosis.

Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia

A. Pfeiffer, B. Otto, M. Vogeser, 2007, Acta Diabetologica.

Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia

B. Otto, K. Parhofer, C. Otto, 2007, Journal of clinical apheresis.

Efficacy and safety of a new whole-blood low-density lipoprotein apheresis system (Liposorber D) in severe hypercholesterolemia.

K. Parhofer, P. Schwandt, S. Kallert, 2003, Artificial organs.

Contribution of fibrinogen and lipoproteins to plasma viscosity in hypercholesterolemia and hypertriglyceridemia: evaluation by selective depletion of low-density lipoproteins or fibrinogen.

P. Schwandt, W. Richter, C. Otto, 2000, Metabolism: clinical and experimental.

Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.

K. Parhofer, C. Otto, H. Geiss, 2006, Metabolism: clinical and experimental.

In vivo metabolism of LDL subfractions in patients with heterozygous FH on statin therapy: rebound analysis of LDL subfractions after LDL apheresis.

S. Bremer, K. Parhofer, P. Barrett, 2004, Journal of lipid research.

Effects of direct adsorption of lipoproteins apheresis on lipoproteins, low-density lipoprotein subtypes, and hemorheology in hypercholesterolemic patients with coronary artery disease.

P. Schwandt, C. Otto, H. Geiss, 2002, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

Effect of atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjects.

K. Parhofer, P. Schwandt, C. Otto, 2001, Metabolism: clinical and experimental.

Effect of atorvastatin on lipid parameters, LDL subtype distribution, hemorrheological parameters and adhesion molecule concentrations in patients with hypertriglyceridemia.

K. Empen, K. Parhofer, M. Lehrke, 2003, Nutrition, metabolism, and cardiovascular diseases : NMCD.

mu-Opiate receptor agonists -- a new pharmacological approach to prevent motion sickness?

P. Enck, B. Otto, R. Riepl, 2006, British journal of clinical pharmacology.

Does ghrelin increase during nausea

P. Enck, B. Otto, J. Klose, 2006 .

Increase in adiponectin levels during pioglitazone therapy in relation to glucose control, insulin resistance as well as ghrelin and resistin levels

A. Pfeiffer, B. Otto, B. Göke, 2006, Journal of endocrinological investigation.

The prevention education program (PEP). A prospective study of the efficacy of family-oriented life style modification in the reduction of cardiovascular risk and disease: design and baseline data.

K. Parhofer, P. Schwandt, W. Richter, 1999, Journal of clinical epidemiology.

Effects of acipimox on haemorheology and plasma lipoproteins in patients with mixed hyperlipoproteinaemia.

K. Parhofer, P. Schwandt, W. Richter, 1998, British journal of clinical pharmacology.

Effects of n-3 fatty acids and fenofibrate on lipid and hemorrheological parameters in familial dysbetalipoproteinemia and familial hypertriglyceridemia.

A. Soennichsen, P. Schwandt, W. Richter, 1996, Metabolism: clinical and experimental.

Influence of fiber, xylitol and fructose in enteral formulas on glucose and lipid metabolism in normal subjects

A. Sönnichsen, P. Schwandt, W. Richter, 1993, The clinical investigator.

Postprandial hemorrheology and apolipoprotein B metabolism in patients with familial hypertriglyceridemia.

A. Soennichsen, P. Schwandt, W. Richter, 1997, Metabolism: clinical and experimental.

Effect of a high-fat meal on the postprandial ghrelin response.

B. Otto, K. Parhofer, C. Otto, 2006, The American journal of clinical nutrition.

The effects of three different LDL‐apheresis methods on the plasma concentrations of E‐selectin, VCAM‐1, and ICAM‐1

K. Empen, K. Parhofer, C. Otto, 2002, Journal of clinical apheresis.

Lack of an association of urinary albumin excretion with interleukin-6 or C-reactive protein in patients with type 2 diabetes

P. Fraunberger, P. Schwandt, C. Otto, 2001, Acta Diabetologica.

Novel insulin sensitizers: pharmacogenomic aspects.

B. Göke, M. Lehrke, C. Otto, 2002, Pharmacogenomics.

Syndrome of Inappropriate Antidiuretic Hormone Secretion Induced by Different Drugs

W. Richter, C. Otto, 1994, The Annals of pharmacotherapy.

Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain.

U. Beisiegel, D. Lütjohann, K. von Bergmann, 2002, Archives of neurology.

Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.

W O Richter, P Schwandt, P. Schwandt, 2001, Metabolism: clinical and experimental.

Hemostatic factors and the risk of myocardial infarction.

W. Richter, C. Otto, 1995, The New England journal of medicine.

Influence of atorvastatin versus simvastatin on fibrinogen and other hemorheological parameters in patients with severe hypercholesterolemia treated with regular low-density lipoprotein immunoadsorption apheresis.

K. Parhofer, P. Schwandt, C. Otto, 2000, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.